Is Wes Streeting Waging a War on Mental Health?

Key Takeaways

• Government launches independent mental health review led by Wes Streeting
• Review targets ADHD, autism prevalence, medicalisation, NHS-private sector role
• Critics warn review may politicise diagnoses and cut services
• Expert study finds ADHD likely underdiagnosed in England
• Private equity profits raise NHS reliance concerns

Summary

The UK government, under Labour’s Wes Streeting, has launched an independent review into mental health conditions, ADHD and autism across all ages. The terms of reference call for an evidence‑backed analysis of prevalence, trends, medicalisation, and the role of both NHS and private providers. Critics argue the review is politically motivated, fearing it could be used to justify cuts or increased private sector involvement. Meanwhile, a recent British Journal of Psychiatry paper involving 32 experts suggests ADHD is actually under‑diagnosed in England, highlighting a need for more resources rather than stricter controls.

Pulse Analysis

The launch of an independent mental‑health review by Wes Streeting marks a rare convergence of health policy and partisan politics in the UK. While the Labour government frames the inquiry as a data‑driven effort to address prevalence, inequalities and the growing burden on the NHS, the timing raises questions. Mental health has long been a cultural flashpoint, and the decision to focus on ADHD and autism now—just months before the next election—suggests a strategic move to reshape public discourse and potentially re‑allocate resources.

Stakeholders are particularly wary of the review’s emphasis on the "role of the independent sector" in diagnosing these conditions. Private equity firms have profited enormously from ADHD clinics that serve NHS patients, a trend that has strained public budgets and sparked concerns about a creeping marketisation of care. Critics fear the review could legitimize further outsourcing, eroding the NHS’s capacity to provide comprehensive, publicly funded services. The political narrative of "overdiagnosis" also risks stigmatising vulnerable groups and diverting attention from systemic under‑investment.

Contrasting the political rhetoric, a recent study published in the British Journal of Psychiatry, authored by 32 leading experts, finds no evidence of ADHD overdiagnosis in England; instead, prevalence data suggest many individuals remain undiagnosed and unsupported. This evidence‑based perspective underscores the need for increased funding, workforce training, and balanced public conversation. If the review stays true to its evidence‑backed promise, it could reinforce the case for expanding NHS capacity rather than retreating to private solutions, ultimately benefiting patients who have long been caught in the crossfire of policy debates.